Cancer cells were treated with Tz-thalidomide (10 μM) for 18 h followed by (+)-JQ1-TCO (3 μM) for another 18 h, or vice versa, to give rise to complete Brd4 degradation. This evidence concerns the gene BRD4 and cancer.